Safety and efficacy of daily oral edaravone (FNP122) in patients with amyotrophic lateral sclerosis (ADORE): a multicentre, double-blind, phase 3, randomised controlled trial

The Lancet Neurology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles